Lee Buckler

@jmacpher Kudos to Cytiva. This is huge! One quick question. Can the paper be eliminated safely before products go into the environmentally monitored quarantined manufacturing materials storage area?

We've been busy eliminating polystyrene in packaging. Our new packaging has liners made with renewable paper and corn starch as their primary ingredients.

This month's @BCAbloodcenters #AdvancedTherapy News is now out featuring the @AllofUsResearch program, decentralized manufacturing, outpatient #celltherapy admin, and much more! mailchi.mp/22a03f70c083/a… Thanks to @getbiolinked for sponsoring + @accellix for the special offer.

@DrPHanley She said "yes" !?! Congrats to you both. 👩‍❤️‍👨

Some personal news to share this week:

@DrPHanley (eee-ro) I think. 👍🏼

@celltherapy Sorry I meant the pronunciation. I can ask them today 🙃

#isct2024 #productlaunch

@DrPHanley Ori spelled backwards.

@celltherapy “Eeero?” “Eyero?”

@XcellBio #ISCT2024 #productlaunch financialpost.com/pmn/business-w…

#ISCT2024 #productlaunch

Join the Decentralized Manufacturing Working Group tomorrow for a discussion on Regulatory Challenges! @cee6db8b-92a4-4631-a1e2-95da75ef8ff7" target="_blank" rel="nofollow noopener">events.teams.microsoft.com/event/e64df5f3…

Did you catch this @BioProcessIntl piece by Brent Morse and Alicja Fiedorowicz? "Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Therapies: Part 1 — In-Process and Drug Product Control." Read now, here! bioprocessintl.com/cell-therapies…

More momentum on the #POC manufacturing front. Enter, regional blood banks. @GalapagosGlobal @BCAbloodcenters glpg.com/press-releases…

Aiming to decentralize CAR-T manufacturing, @GalapagosGlobal partners with largest US blood supply network - endpts.com/aiming-to-dece…

@GalapagosGlobal is... "teaming up with the largest blood supply network in the U.S. to help realize its decentralized production ambitions for CAR-T therapies on a national scale." "Late Wednesday, Galapagos unveiled a new pact with @BCAbloodcenters (BCA), gaining access to the collection and donation network’s 50-plus community blood centers across 43 states to assist with manufacturing of Galapagos’ clinical CAR-T programs in hematology/oncology." #decentralizedmanufacturing #celltherapy @BCACellTherapy

#decentralized #manufacturing #celltherapy #cart #advancedtherapies @Phacilitate @ISCTglobal @AABB @ASGCTherapy @alliancerm

Fulfilling the promise of cell & gene therapies through manufacturing (Part I) fiercepharma.com/manufacturing/…

@harisvromas @adamfeuerstein @BrianSkorney One could imagine a scenario where a company might have the processes and patients lined up to almost immediately do collections but perhaps there are complexities which are not contemplated in this imaginary world of preparedness.

@adamfeuerstein @BrianSkorney Given a) it takes several months to complete the treatment b) investors are seeking visibility on the numbers and c) the treatment was approved in Dec, what else could be the case?

No. of NY Times stories about cell collection: $BLUE 1 $VRTX 0 No. of patients undergoing cell collection: $VRTX 5 $BLUE 1

Please note @LeeBuckler4 is a fake account. Please report it and block it. #fakeaccount. Thank you @DrPHanley for alerting me.

@darkhorsecagt Also super curious that the Pegasi data suggest 15% growth in market share for Allo but the VOC data anticipates no material change in transport/logistics costs over 5 years. That's a curious disconnect.

This visual takes a look at 4 market trends. The 2 on the L came thru our Pegasi quant modeling & the 2 of the R came thru Voice of Customer (VOC) interviews. If you're not part of our VOC database, that's easily remedied by signing up here: darkhorseconsultinggroup.com/voc (3/3)

This "World of CGT CDMOs" image gives us a snapshot of regional CDMO offerings around the globe using our DHC CDMO database. If you have a CDMO that's not in our database, fill out this form darkhorseconsultinggroup.com/cdmo so that we can ask you some questions and add it. (2/3)

@darkhorsecagt These wereare great graphics. Thank you! Trying to understand the auto/allo graph. May we also assume this is from data "as of 2022"? If so, is there any material difference between this and the actual data on the auto/allo breakdown as of the end of 2023?

NY Governor Releases Request for Proposals for State-of-the-Art Cell and Gene Therapy Hub on Long Island. More Than $150M Available Builds on Governor’s Commitment to Boosting Fast Growing Sectors Like Life Sciences — Including State Commitment to Establishing Two Cell and Gene Therapy Hubs New Hub Will Help to Position New York State as National Leader in Cell and Gene Therapies governor.ny.gov/news/governor-…